New genetic biomarkers predicting 5-aminosalicylate-induced adverse events in patients with inflammatory bowel diseases.
Jihye ParkI Seul ParkJi Hyung KimJung Hyun JiSoo Jung ParkJae Jun ParkTae Il KimSeung Won KimJae Hee CheonPublished in: Therapeutic advances in gastroenterology (2024)
was the most significant genetic locus contributing to 5-ASA's adverse event risk.